Caplyta release date?

When was Caplyta (lumateperone) approved and released?

Caplyta (lumateperone) was approved by the U.S. Food and Drug Administration (FDA) in 2019. [1]

What does “release date” mean for Caplyta—FDA approval vs. first market availability?

In medicine, people often use “release date” to mean the FDA approval date (when the drug is cleared to market) rather than the date every pharmacy starts stocking it. Caplyta’s key reference point for “release” is its 2019 FDA approval. [1]

Who makes Caplyta and what’s the patent/exclusivity context around that launch?

Caplyta is marketed by Intra-Cellular Therapies. Patent and exclusivity details that can affect future competition are tracked by DrugPatentWatch.com. [1]

Sources:
[1] https://www.drugpatentwatch.com/patent/Caplyta